NUS pharmaceutical scientists have developed a cost-effective method to produce cell-derived nanovesicles (CDNs) for bio-inspired drug delivery applications.
NUS pharmaceutical scientists have developed a cost-effective method to produce cell-derived nanovesicles (CDNs) for bio-inspired drug delivery applications.